MoneyWorks4Me

Supriya Lifescience - Quaterly Results

20 May 2022 Evaluate
The sales surged to Rs. 1812.69 millions, up 37.21% for the March 2022 quarter as against Rs. 1321.07 millions during the corresponding quarter previous year.The Net Profit of the company registered a slight decline of -4.73% to Rs. 462.12  millions from Rs. 485.07 millions.Operating profit for the quarter ended March 2022 rose to 790.78 millions as compared to 686.68 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1812.69 1321.07 37.21 5300.49 3912.45 35.48 5300.49 3912.45 35.48
Other Income 38.55 15.02 156.66 75.77 49.77 52.24 75.77 49.77 52.24
PBIDT 790.78 686.68 15.16 2215.62 1781.51 24.37 2215.62 1781.51 24.37
Interest 10.17 12.42 -18.12 41.98 40.80 2.89 41.98 40.80 2.89
PBDT 780.61 674.26 15.77 2173.64 1740.71 24.87 2173.64 1740.71 24.87
Depreciation 25.79 17.84 44.56 101.18 67.61 49.65 101.18 67.61 49.65
PBT 754.82 656.42 14.99 2072.46 1673.10 23.87 2072.46 1673.10 23.87
TAX 292.70 171.35 70.82 554.35 437.16 26.81 554.35 437.16 26.81
Deferred Tax 108.25 -3.50 -3192.86 32.46 6.94 367.72 32.46 6.94 367.72
PAT 462.12 485.07 -4.73 1518.11 1235.94 22.83 1518.11 1235.94 22.83
Equity 160.97 146.37 9.97 160.97 146.37 9.97 160.97 146.37 9.97
PBIDTM(%) 43.62 51.98 -16.07 41.80 45.53 -8.20 41.80 45.53 -8.20
Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..